Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease.

Numerous studies have shown the neuroprotective and regenerative benefits of glial cell line-derived neurotrophic factor (GDNF) in animal models of PD. Brain delivery of GDNF can, however, be associated with limiting side-effects in both primates and PD patients, rendering the duration of delivery a critical factor. In the present study, the effects of transient vs. sustained GDNF delivery by encapsulated cells were evaluated in a bilateral animal model, closely mimicking advanced PD. One week following bilateral striatal 6-hydroxydopamine injections in rats, capsules loaded with human fibroblasts genetically engineered to release GDNF were bilaterally implanted in the striatum. GDNF delivery resulted in a significant improvement of movement initiation and swimming performance in the lesioned animals, associated with striatal reinnervation of dopaminergic fibers. To test the sustainability of the behavioral improvement, GDNF-secreting capsules were withdrawn in a subgroup of animals, 7 weeks post-implantation. Strikingly, both the behavioral and morphological improvements were maintained until the sacrifice of the animals 6 weeks post-GDNF withdrawal. The sustained cellular and behavioral benefits after GDNF washout suggest the need for temporary delivery of the trophic factor in PD. Retrievable encapsulated cells represent an attractive delivery tool to achieve this purpose.
AuthorsAli Sajadi, Jean-Charles Bensadoun, Bernard L Schneider, Christophe Lo Bianco, Patrick Aebischer
JournalNeurobiology of disease (Neurobiol Dis) Vol. 22 Issue 1 Pg. 119-29 (Apr 2006) ISSN: 0969-9961 [Print] United States
PMID16300956 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glial Cell Line-Derived Neurotrophic Factor
  • Oxidopamine
  • Dopamine
  • Animals
  • Behavior, Animal (physiology)
  • Cell Line, Transformed
  • Corpus Striatum (cytology, metabolism, surgery)
  • Denervation
  • Disease Models, Animal
  • Dopamine (metabolism)
  • Female
  • Fibroblasts (metabolism, secretion, transplantation)
  • Genetic Engineering (methods)
  • Glial Cell Line-Derived Neurotrophic Factor (metabolism, secretion)
  • Growth Cones (metabolism)
  • Humans
  • Motor Activity (physiology)
  • Nerve Regeneration (physiology)
  • Neuronal Plasticity (physiology)
  • Oxidopamine
  • Parkinsonian Disorders (therapy)
  • Rats
  • Rats, Sprague-Dawley
  • Recovery of Function (physiology)
  • Swimming (physiology)
  • Tissue Transplantation (methods)
  • Up-Regulation (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: